Tweet
No cases of adverse event involving blood clots have been reported in India in the case of the Oxford-AstraZeneca vaccine, according to top officials involved in the country’s coronavirus inoculation campaign, who also said a deeper review of post-vaccination side effects will be carried out next week.
